Home › Funds › Cormorant Asset Management, LP › DFTX

Cormorant Asset Management, LP position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

Cormorant Asset Management, LP reported holding 275,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.5M, representing 0.75% of its reported portfolio and ranking #35 among its reported holdings. Cormorant Asset Management, LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)275.00K sh
Reported value held$10.47M
Portfolio Weight0.75%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's DFTX position evolved

Cormorant Asset Management, LP first disclosed a stake in DFTX in Q2 2026 at 400,000 shares (US$18.8M). Across 2 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 275,000 shares valued at US$10.5M — a reduction of -125,000 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 400.00K $18.82M New
Q3 2026 275.00K $10.47M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 112 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$268.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$258.4M), Octagon Capital Advisors LP (US$95.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has Cormorant Asset Management, LP held DFTX?

Cormorant Asset Management, LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Cormorant Asset Management, LP's current position in DFTX?

As of Q3 2026, Cormorant Asset Management, LP holds 275.00K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $10.47M, representing 0.75% of its reported portfolio and ranking #35.

Has Cormorant Asset Management, LP been buying or selling DFTX?

In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP reduced its position in DFTX.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 112 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.